TMCnet News
Cancer Markers - Key Players are Abbott Laboratories, Hologic & Thermo Fisher Scientific - Research and MarketsResearch and Markets has announced the addition of the "Cancer Markers" report to their offering. Cancer is the number two cause of death, behind only cardiovascular disease. The most common types of cancer worldwide include breast cancer, colorectal cancer, lung cancer, and prostate cancer. For these and other types of cancer, novel biomarkers, therapies, and diagnostic tests are being developed. Cancer Markers provides market assessment, estimate and competitive analysis for tests for oncology that use biomarkers. This includes a range of technologies made by scores of companies. The report contains products designed to determine risk for cancer, screen for cancer, test for cancer, aid in prognosis and personalize therapy. Among the technologies are the following:
Estimates for these segments are provided for 2015 and 2020. In addition, some specific marker breakouts are provided along with significant detail of products on the market. This report reviews the progression of cancer diagnostic technologies over the past 10-15 years and notes some trends in test strategies as well. Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INTRODUCTION THREE: CANCER MARKERS MARKET ANALYSIS FOUR: COMPANY PROFILES
For more information visit http://www.researchandmarkets.com/research/76r4zj/cancer_markers View source version on businesswire.com: http://www.businesswire.com/news/home/20160420005789/en/ |
